Your browser doesn't support javascript.
loading
Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34).
Singer, Christian F; Pfeiler, Georg; Hubalek, Michael; Bartsch, Rupert; Stöger, Herbert; Pichler, Angelika; Petru, Edgar; Bjelic-Radisic, Vesna; Greil, Richard; Rudas, Margaretha; Maria Tea, Muy-Kheng; Wette, Viktor; Petzer, Andreas L; Sevelda, Paul; Egle, Daniel; Dubsky, Peter C; Filipits, Martin; Fitzal, Florian; Exner, Ruth; Jakesz, Raimund; Balic, Marija; Tinchon, Christoph; Bago-Horvath, Zsuzsanna; Frantal, Sophie; Gnant, Michael.
Afiliação
  • Singer CF; Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria. Electronic address: christian.singer@meduniwien.ac.at.
  • Pfeiler G; Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria.
  • Hubalek M; Breast Center Schwaz, BKH Schwaz, Schwaz, Austria.
  • Bartsch R; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.
  • Stöger H; Division of Oncology, Department of Internal Medicine and Comprehensive Cancer Center, Medical University of Graz, Graz, Austria.
  • Pichler A; Department of Hemato-Oncology, LKH Hochsteiermark-Leoben, Leoben, Austria.
  • Petru E; Department of Gynecology and Obstetrics, Medical University of Graz, Graz, Austria.
  • Bjelic-Radisic V; Breast Unit, Helios University Hospital Wuppertal, University Witten/Herdecke, Wuppertal Germany, Germany.
  • Greil R; Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Disease, Rheumatology, Oncologic Center, Laboratory for Immunological and Molecular Cancer Research, Paracelsus Medical University, Salzburg Cancer Research Institute-CCCIT, Cancer Cluster Salzburg, Sal
  • Rudas M; Department of Pathology, Medical University of Vienna, Medical University of Vienna, Vienna, Austria.
  • Maria Tea MK; Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria.
  • Wette V; Breastcenter Carinthia, St. Veit, Austria.
  • Petzer AL; Internal Medicine I, Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Ordensklinikum Linz Barmherzige Schwestern, Elisabethinen, Linz, Austria.
  • Sevelda P; Karl Landsteiner Institute for Gynecologic Oncology and Senology, Vienna, Austria.
  • Egle D; Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria.
  • Dubsky PC; Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Breastcenter St. Anna, Lucerne, Switzerland.
  • Filipits M; Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Fitzal F; Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Exner R; Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Jakesz R; Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Balic M; Division of Oncology, Department of Internal Medicine and Comprehensive Cancer Center, Medical University of Graz, Graz, Austria.
  • Tinchon C; Department of Hemato-Oncology, LKH Hochsteiermark-Leoben, Leoben, Austria.
  • Bago-Horvath Z; Department of Pathology, Medical University of Vienna, Medical University of Vienna, Vienna, Austria.
  • Frantal S; Department of Statistics, Austrian Breast & Colorectal Cancer Study Group (ABCSG), Vienna, Austria.
  • Gnant M; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Eur J Cancer ; 132: 43-52, 2020 06.
Article em En | MEDLINE | ID: mdl-32325419

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Glicoproteínas de Membrana / Biomarcadores Tumorais / Vacinas Anticâncer Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Glicoproteínas de Membrana / Biomarcadores Tumorais / Vacinas Anticâncer Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2020 Tipo de documento: Article